Abiomed Inc
ABMD
ABMD was delisted on the 21st of December, 2022.
483 hedge funds and large institutions have $10.9B invested in Abiomed Inc in 2019 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 190 increasing their positions, 185 reducing their positions, and 111 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 190 | Existing positions reduced: 185
4% less capital invested
Capital invested by funds: $11.4B → $10.9B (-$468M)
14% less funds holding
Funds holding: 559 → 483 (-76)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
50% less call options, than puts
Call options by funds: $123M | Put options by funds: $247M
59% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 111
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$302M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$222M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$167M |
| 4 |
Renaissance Technologies
New York
|
+$98.4M |
| 5 |
BlackRock
New York
|
+$77M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$121M |
| 2 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
-$111M |
| 3 |
Goldman Sachs
New York
|
-$82.6M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$51.2M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$49.3M |
ABMD Hedge Fund Activity: Q2 2019 in Review
483 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2019, worth a combined $10.9B — down 4.1% from $11.4B a quarter earlier.
Sellers outnumbered buyers: 111 funds closed out of ABMD and 45 opened new positions — a net loss of 66 holders — while 185 trimmed existing stakes and 190 added.
The largest buyer was Baillie Gifford & Co, adding an estimated $302M. The largest seller was AQR Capital Management, cutting an estimated $121M.
- 483 institutional investors held Abiomed Inc (ABMD) as of Q2 2019, down from 559 in Q1 2019.
- Funds reported $10.9B of Abiomed Inc stock for Q2 2019, down 4.1% quarter-over-quarter.
- 45 funds opened new Abiomed Inc positions in Q2 2019 and 111 closed out, a net change of -66 holders.
- The largest Abiomed Inc buyer in Q2 2019 was Baillie Gifford & Co, an estimated $302M added.
- The largest Abiomed Inc seller in Q2 2019 was AQR Capital Management, an estimated $121M sold.
Based on aggregated 13F filings for Q2 2019.